Reimagining CLM’s Role in the Biopharmaceutical Space
SirionLabs
JUNE 13, 2022
According to researchers at Tufts University’s Center for the Study of Drug Development, there has been a hefty increase in the total number of procedures across trial phases ; a 69% growth in Phase II and a 49% growth in Phase III. Sirion’s AI-led legal review feature minimizes risky or missed clauses.
Let's personalize your content